{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:39:02Z","timestamp":1772271542590,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,18]]},"DOI":"10.7759\/cureus.24246","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T12:50:25Z","timestamp":1650286225000},"source":"Crossref","is-referenced-by-count":3,"title":["Is Edema Zone Volume Associated With Ki-67 Index in Glioblastoma Patients?"],"prefix":"10.7759","author":[{"given":"Ricardo","family":"Caramanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raysa M","family":"Apr\u00edgio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E","family":"D`Aglio Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionei F","family":"Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rio J","family":"G\u00f3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feres","family":"Chaddad-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldir A","family":"Tognola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016","volume":"21","author":"Ostrom QT","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016. Neuro Oncol. 2019, 21:v1-v100. 10.1093\/neuonc\/noz150","journal-title":"Neuro Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nor052","article-title":"A multicenter study of primary brain tumor incidence in Australia (2000-2008)","volume":"13","author":"Dobes M","year":"2011","unstructured":"Dobes M, Shadbolt B, Khurana VG, et al.. A multicenter study of primary brain tumor incidence in Australia (2000-2008). Neuro Oncol. 2011, 13:783-90. 10.1093\/neuonc\/nor052","journal-title":"Neuro Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy164","article-title":"Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland","volume":"21","author":"Korja M","year":"2019","unstructured":"Korja M, Raj R, Sepp\u00e4 K, et al.. Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland. Neuro Oncol. 2019, 21:370-9. 10.1093\/neuonc\/noy164","journal-title":"Neuro Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now166","article-title":"Cancers of the brain and CNS: global patterns and trends in incidence","volume":"19","author":"Miranda-Filho A","year":"2017","unstructured":"Miranda-Filho A, Pi\u00f1eros M, Soerjomataram I, Deltour I, Bray F. Cancers of the brain and CNS: global patterns and trends in incidence. Neuro Oncol. 2017, 19:270-80. 10.1093\/neuonc\/now166","journal-title":"Neuro Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp R","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, et al.. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005, 352:987-96. 10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2018.05.002","article-title":"Ten-year survival in glioblastoma. A systematic review","volume":"54","author":"Tykocki T","year":"2018","unstructured":"Tykocki T, Eltayeb M. Ten-year survival in glioblastoma. A systematic review. J Clin Neurosci. 2018, 54:7-13. 10.1016\/j.jocn.2018.05.002","journal-title":"J Clin Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.1373","article-title":"Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis","volume":"2","author":"Brown TJ","year":"2016","unstructured":"Brown TJ, Brennan MC, Li M, et al.. Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol. 2016, 2:1460-9. 10.1001\/jamaoncol.2016.1373","journal-title":"JAMA Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2008.00956.x","article-title":"Outcome evaluation in glioblastoma patients using different ranking scores: KPS, GOS, mRS and MRC","volume":"19","author":"Stark AM","year":"2010","unstructured":"Stark AM, Stepper W, Mehdorn HM. Outcome evaluation in glioblastoma patients using different ranking scores: KPS, GOS, mRS and MRC. Eur J Cancer Care (Engl). 2010, 19:39-44. 10.1111\/j.1365-2354.2008.00956.x","journal-title":"Eur J Cancer Care (Engl)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2001.95.2.0190","article-title":"A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival","volume":"95","author":"Lacroix M","year":"2001","unstructured":"Lacroix M, Abi-Said D, Fourney DR, et al.. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001, 95:190-8. 10.3171\/jns.2001.95.2.0190","journal-title":"J Neurosurg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025451","article-title":"Radiogenomic mapping of edema\/cellular invasion MRI-phenotypes in glioblastoma multiforme","volume":"6","author":"Zinn PO","year":"2011","unstructured":"Zinn PO, Mahajan B, Sathyan P, Singh SK, Majumder S, Jolesz FA, Colen RR. Radiogenomic mapping of edema\/cellular invasion MRI-phenotypes in glioblastoma multiforme. PLoS One. 2011, 6:e25451. 10.1371\/journal.pone.0025451","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2015.16.2.411","article-title":"Ki-67 is a valuable prognostic factor in gliomas: evidence from a systematic review and meta-analysis","volume":"16","author":"Chen WJ","year":"2015","unstructured":"Chen WJ, He DS, Tang RX, Ren FH, Chen G. Ki-67 is a valuable prognostic factor in gliomas: evidence from a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2015, 16:411-20. 10.7314\/apjcp.2015.16.2.411","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.580750","article-title":"Assessment of prognostic value of cystic features in glioblastoma relative to sex and treatment with standard-of-care","volume":"10","author":"Curtin L","year":"2020","unstructured":"Curtin L, Whitmire P, Rickertsen CR, et al.. Assessment of prognostic value of cystic features in glioblastoma relative to sex and treatment with standard-of-care. Front Oncol. 2020, 10:580750. 10.3389\/fonc.2020.580750","journal-title":"Front Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040722","article-title":"Prognostic and predictive value of integrated qualitative and quantitative magnetic resonance imaging analysis in glioblastoma","volume":"13","author":"Verduin M","year":"2021","unstructured":"Verduin M, Primakov S, Compter I, et al.. Prognostic and predictive value of integrated qualitative and quantitative magnetic resonance imaging analysis in glioblastoma. Cancers (Basel). 2021, 13:10.3390\/cancers13040722","journal-title":"Cancers (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12826","article-title":"Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma","volume":"15","author":"Wong E","year":"2019","unstructured":"Wong E, Nahar N, Hau E, et al.. Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma. Asia Pac J Clin Oncol. 2019, 15:5-9. 10.1111\/ajco.12826","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-555534\/v1","article-title":"Is edema zone volume associated with Ki-67 index in glioblastoma patients?","author":"Caramanti RL","year":"2021","unstructured":"Caramanti RL, Chaddad-Neto F, Morais D, Rocha C, Marques LH, Tognola W, G\u00f3es MJ.. Is edema zone volume associated with Ki-67 index in glioblastoma patients?. Reseach Square. 2021, 10.21203\/rs.3.rs-555534\/v1","journal-title":"Reseach Square"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2014.15.12.4969","article-title":"Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells","volume":"15","author":"Dang YW","year":"2014","unstructured":"Dang YW, Zeng J, He RQ, Rong MH, Luo DZ, Chen G. Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells. Asian Pac J Cancer Prev. 2014, 15:4969-76. 10.7314\/apjcp.2014.15.12.4969","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref17","unstructured":"Horos project. (2018). Accessed. 10\/06\/2018: https:\/\/horosproject.org."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nature18610","article-title":"Ki-67 acts as a biological surfactant to disperse mitotic chromosomes","volume":"535","author":"Cuylen S","year":"2016","unstructured":"Cuylen S, Blaukopf C, Politi AZ, et al.. Ki-67 acts as a biological surfactant to disperse mitotic chromosomes. Nature. 2016, 535:308-312. 10.1038\/nature18610","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2018.11.001","article-title":"Ki-67 labeling index in glioblastoma; does it really matter?","volume":"12","author":"Alkhaibary A","year":"2019","unstructured":"Alkhaibary A, Alassiri AH, AlSufiani F, Alharbi MA. Ki-67 labeling index in glioblastoma; does it really matter?. Hematol Oncol Stem Cell Ther. 2019, 12:82-8. 10.1016\/j.hemonc.2018.11.001","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref20","article-title":"Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas","volume":"21","author":"Shimizu H","year":"2000","unstructured":"Shimizu H, Kumabe T, Shirane R, Yoshimoto T. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol. 2000, 21:659-65.","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.02.006","article-title":"Correlation of Ki-67 index with volumetric segmentation and its value as a prognostic marker in glioblastoma","volume":"125","author":"Henker C","year":"2019","unstructured":"Henker C, Kriesen T, Schneider B, et al.. Correlation of Ki-67 index with volumetric segmentation and its value as a prognostic marker in glioblastoma. World Neurosurg. 2019, 125:e1093-103. 10.1016\/j.wneu.2019.02.006","journal-title":"World Neurosurg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106126","article-title":"Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter progression free survival? A clinical and molecular analytic investigation","volume":"198","author":"Armocida D","year":"2020","unstructured":"Armocida D, Frati A, Salvati M, Santoro A, Pesce A. Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter progression free survival? A clinical and molecular analytic investigation. Clin Neurol Neurosurg. 2020, 198:106126. 10.1016\/j.clineuro.2020.106126","journal-title":"Clin Neurol Neurosurg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6511-6","article-title":"Prognostic factors of patients with gliomas - an analysis on 335 patients with Glioblastoma and other forms of Gliomas","volume":"20","author":"Liang J","year":"2020","unstructured":"Liang J, Lv X, Lu C, et al.. Prognostic factors of patients with gliomas - an analysis on 335 patients with Glioblastoma and other forms of Gliomas. BMC Cancer. 2020, 20:35. 10.1186\/s12885-019-6511-6","journal-title":"BMC Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2478\/chilat-2014-0102","article-title":"Heterogeneity of Ki-67 and p53 expression in glioblastoma","volume":"14","author":"Jakovlevs A","year":"2014","unstructured":"Jakovlevs A, Vanags A, Balodis D. Heterogeneity of Ki-67 and p53 expression in glioblastoma. Acta Chir Latv. 2014, 14:11-14. 10.2478\/chilat-2014-0102","journal-title":"Acta Chir Latv"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-015-2005-9","article-title":"Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme","volume":"126","author":"Henker C","year":"2016","unstructured":"Henker C, Kriesen T, F\u00fcrst K, Goody D, Glass \u00c4, P\u00fctzer BM, Piek J. Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme. J Neurooncol. 2016, 126:585-92. 10.1007\/s11060-015-2005-9","journal-title":"J Neurooncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-017-2587-5","article-title":"Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival","volume":"135","author":"Henker C","year":"2017","unstructured":"Henker C, Kriesen T, Glass \u00c4, Schneider B, Piek J. Volumetric quantification of glioblastoma: experiences with different measurement techniques and impact on survival. J Neurooncol. 2017, 135:391-402. 10.1007\/s11060-017-2587-5","journal-title":"J Neurooncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/0284185114554822","article-title":"Volumetric glioma quantification: comparison of manual and semi-automatic tumor segmentation for the quantification of tumor growth","volume":"56","author":"Odland A","year":"2015","unstructured":"Odland A, Server A, Saxhaug C, et al.. Volumetric glioma quantification: comparison of manual and semi-automatic tumor segmentation for the quantification of tumor growth. Acta Radiol. 2015, 56:1396-403. 10.1177\/0284185114554822","journal-title":"Acta Radiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/85919-is-edema-zone-volume-associated-with-ki-67-index-in-glioblastoma-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:41:18Z","timestamp":1707489678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/85919-is-edema-zone-volume-associated-with-ki-67-index-in-glioblastoma-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.24246","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-555534\/v1","asserted-by":"object"}]},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,18]]}}}